With students heading back to the classrooms and cooler fall temperatures right around the corner, doctors are sounding the alarm on a recent uptick in COVID cases.
COVID hospitalizations have been increasing, from about 6,000 a week at the beginning of the summer to more than 15,000 the week of Aug. 19, the most recent week of federal data. But in 96% of the country, COVID hospitalizations are considered low, according to the CDC.
The uptick in COVID data comes as federal health officials could soon announce an updated booster shot and with it new recommendations about who should get the jab. Even with the uptick in cases, Dr. Cirigliano said the country is in a much different place than it was at the height of the COVID-19 pandemic.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FDA could green light new Covid boosters as early as FridayThe shots could become available next week, after the Centers for Disease Control and Prevention also signs off.
Weiterlesen »
FDA could greenlight new COVID boosters as early as FridayThe Food and Drug Administration plans to greenlight updated versions of the COVID-19 booster as early as Friday, according to four people familiar with the agency’s plans.
Weiterlesen »
FDA May Approve New Covid Boosters By Friday As Deaths Spike, Report SaysAt the recommendation of the FDA, the new boosters protect against XBB variants, which made up 95% of all U.S. Covid cases in June.
Weiterlesen »
Weight loss product sold on Amazon, Walmart could be fatal, FDA saysThe FDA announced Todorganic Inc. is recalling Nuez de la India seeds because they appear to actually be yellow oleander seeds, which are toxic.
Weiterlesen »
Vyvanse Generics Approved by FDAThe FDA approval of generic versions of Vyvanse (lisdexamfetamine dimesylate) capsules and chewable tablets will likely ease cost and accessibility barriers to prescription stimulants for ADHD.
Weiterlesen »